HDAC1 and metabolic dysfunction-associated steatohepatitis: Decreased nuclear METTL3 may lead to impairment of the METTL3/HDAC1/2 axis, which further increases hepatic free fatty acid uptake and liver inflammation, contributing to NASH progression.